Lidogalen

Lidocaine, the active ingredient in Lidogalen, is a local anesthetic presented as a topical preparation for cutaneous use. It provides local anesthesia for minor skin procedures and relieves pain from superficial skin lesions in patients of all ages. GNH USA supplies Lidogalen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lidogalen is a topical local anesthetic used on the skin to manage pain and facilitate minor procedures. - Minor skin procedures: provides local anesthesia to reduce pain during excision, biopsy, or laser treatment. - Superficial skin lesions: alleviates pain associated with burns, abrasions, or insect bites. - Diagnostic skin testing: numbs skin to improve patient comfort during patch testing.

Lidogalen may cause adverse reactions at the site of application or systemically if absorbed in excess.

Common Side Effects: - Skin irritation: mild redness or discomfort at the application site. - Burning sensation: transient warmth or stinging after application. - Itching: localized pruritus. - Edema: slight swelling of the treated area. - Allergic contact dermatitis: localized rash in sensitised individuals. - Dryness: mild desiccation of the skin.

Serious or Rare Side Effects: - Systemic toxicity: CNS symptoms such as dizziness, tinnitus, or seizures. - Cardiovascular effects: arrhythmias or hypotension in cases of high systemic absorption. - Anaphylaxis: severe allergic reaction with airway compromise. - Methemoglobinemia: rare blood disorder causing reduced oxygen delivery. - Severe skin necrosis: extensive tissue damage at the application site. - Persistent numbness: prolonged loss of sensation beyond the expected duration.

When using Lidogalen, consider the following safety measures. - Allergy assessment: avoid use in patients with known lidocaine hypersensitivity. - Application area: limit to intact skin and avoid mucous membranes. - Quantity control: do not exceed recommended surface area to prevent systemic absorption. - Concurrent anesthetics: avoid simultaneous use with other topical anesthetics containing similar agents. - Special populations: use caution in infants and elderly due to altered metabolism. - Store at ambient temperature: keep below 25 °C, protect from moisture and direct sunlight.

Lidogalen can interact with certain systemic medications; review patient medication lists before use.

Major Interactions (Avoid): - Class I antiarrhythmics (e.g., quinidine, procainamide): may increase lidocaine plasma levels and risk toxicity. - Strong CYP3A4 inhibitors (e.g., ketoconazole): can reduce lidocaine metabolism, leading to accumulation. - Other topical anesthetics: additive local or systemic toxicity when combined.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may enhance cardiac depressant effects of lidocaine. - Diuretics (e.g., furosemide): may alter plasma protein binding, affecting lidocaine levels. - Alcohol: can increase systemic absorption when large skin areas are treated.